AKT1 and Insulin resistance: We found that PP2A inhibition increased white adipose tissue insulin sensitivity and resulted in a marked enhancement of insulin signaling through the Akt node, but nevertheless exacerbated whole-body and hepatic insulin resistance through an impairment of insulin-stimulated glycogen synthesis.